Evidence map›Paper›PMID 41225093›Full record

ReviewAdvances in experimental medicine and biology2026

The Role of Short-Chain Fatty Acids Produced by Oral Bacteria in Modulating Oral Immunity.

Hiromasa Tsuda, Yoshikazu Mikami

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hiromasa TsudaDepartment of Biochemistry, Nihon University School of Dentistry, Tokyo, Japan. tsuda.hiromasa@nihon-u.ac.jp.
Yoshikazu MikamiDivision of Microscopic Anatomy, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dental plaque is a complex biofilm composed of various bacterial species. These bacteria metabolize nutrients, producing high concentrations of short-chain fatty acids (SCFAs) as metabolic by-products, including acetate, propionate, butyrate, isobutyrate, isovalerate, and others. SCFAs are also produced by colonic bacteria. Given that the concentration of SCFAs is significantly higher in the colon than in dental plaque, most of the existing literature focuses on the intestinal context. Following the discovery of SCFA receptors, transporters, and their histone deacetylase (HDAC) inhibitory activities, research on the effects of SCFAs on the immune system has gained increasing attention. Additionally, certain SCFAs induce cell death in periodontal tissues, leading to the release of intracellular molecules that act as damage-associated molecular patterns (DAMPs), thereby influencing the immune system. In this chapter, we first describe oral bacteria that produce SCFAs and compare the concentrations of these SCFAs in the oral cavity with those in the intestinal tract. Then, we provide an overview of the SCFA receptors, the transporters required for their transmembrane passage, and the histone deacetylase inhibitory effects of certain SCFAs. We then discuss how these mechanisms contribute to, or are hypothesized to influence, the effects of SCFAs on various immune cells. After reviewing various forms of cell death capable of triggering DAMP release, we will discuss the potential role of SCFA-induced gingival epithelial cell death in promoting the release of DAMPs and its contribution to gingival inflammation.

Indexed as

BacteriaDental PlaqueFatty Acids, VolatileMouthAnimalsHumansFatty Acids, VolatileCell deathDamage-associated molecular patterns (DAMPs)Epithelial cellsInnate immunityShort-chain fatty acids (SCFAs)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.